181 related articles for article (PubMed ID: 30425048)
1. CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.
Edwards DK; Watanabe-Smith K; Rofelty A; Damnernsawad A; Laderas T; Lamble A; Lind EF; Kaempf A; Mori M; Rosenberg M; d'Almeida A; Long N; Agarwal A; Sweeney DT; Loriaux M; McWeeney SK; Tyner JW
Blood; 2019 Feb; 133(6):588-599. PubMed ID: 30425048
[TBL] [Abstract][Full Text] [Related]
2. Colony-stimulating factor 1 and its receptor are new potential therapeutic targets for allergic asthma.
Moon HG; Kim SJ; Lee MK; Kang H; Choi HS; Harijith A; Ren J; Natarajan V; Christman JW; Ackerman SJ; Park GY
Allergy; 2020 Feb; 75(2):357-369. PubMed ID: 31385613
[TBL] [Abstract][Full Text] [Related]
3. Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.
Cannarile MA; Weisser M; Jacob W; Jegg AM; Ries CH; Rüttinger D
J Immunother Cancer; 2017 Jul; 5(1):53. PubMed ID: 28716061
[TBL] [Abstract][Full Text] [Related]
4. Identification of compound D2923 as a novel anti-tumor agent targeting CSF1R.
Liu YQ; Wang YN; Lu XY; Tong LJ; Li Y; Zhang T; Xun QJ; Feng F; Chen YZ; Su Y; Shen YY; Chen Y; Geng MY; Ding K; Li YL; Xie H; Ding J
Acta Pharmacol Sin; 2018 Nov; 39(11):1768-1776. PubMed ID: 29968849
[TBL] [Abstract][Full Text] [Related]
5. S-nitrosylation of CSF1 receptor increases the efficacy of CSF1R blockage against prostate cancer.
Firdaus F; Kuchakulla M; Qureshi R; Dulce RA; Soni Y; Van Booven DJ; Shah K; Masterson T; Rosete OJ; Punnen S; Hare JM; Ramasamy R; Arora H
Cell Death Dis; 2022 Oct; 13(10):859. PubMed ID: 36209194
[TBL] [Abstract][Full Text] [Related]
6. Csf1r or Mer inhibition delays liver regeneration via suppression of Kupffer cells.
Santamaria-Barria JA; Zeng S; Greer JB; Beckman MJ; Seifert AM; Cohen NA; Zhang JQ; Crawley MH; Green BL; Loo JK; Maltbaek JH; DeMatteo RP
PLoS One; 2019; 14(5):e0216275. PubMed ID: 31042769
[TBL] [Abstract][Full Text] [Related]
7. CSF1R inhibition with PLX5622 affects multiple immune cell compartments and induces tissue-specific metabolic effects in lean mice.
Bosch AJT; Keller L; Steiger L; Rohm TV; Wiedemann SJ; Low AJY; Stawiski M; Rachid L; Roux J; Konrad D; Wueest S; Tugues S; Greter M; Böni-Schnetzler M; Meier DT; Cavelti-Weder C
Diabetologia; 2023 Dec; 66(12):2292-2306. PubMed ID: 37792013
[TBL] [Abstract][Full Text] [Related]
8. Colony Stimulating Factor 1 Receptor in Acute Myeloid Leukemia.
Sletta KY; Castells O; Gjertsen BT
Front Oncol; 2021; 11():654817. PubMed ID: 33842370
[TBL] [Abstract][Full Text] [Related]
9. Role of interleukins in acute myeloid leukemia.
Wang Y; Tang X; Zhu Y; Yang XX; Liu B
Leuk Lymphoma; 2023; 64(8):1400-1413. PubMed ID: 37259867
[TBL] [Abstract][Full Text] [Related]
10. Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia.
Knorr K; Rahman J; Erickson C; Wang E; Monetti M; Li Z; Ortiz-Pacheco J; Jones A; Lu SX; Stanley RF; Baez M; Fox N; Castro C; Marino AE; Jiang C; Penson A; Hogg SJ; Mi X; Nakajima H; Kunimoto H; Nishimura K; Inoue D; Greenbaum B; Knorr D; Ravetch J; Abdel-Wahab O
Nat Cancer; 2023 Dec; 4(12):1675-1692. PubMed ID: 37872381
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Skin Biopsy as a Diagnostic Biomarker in CSF1R-Related Disorder.
Dulski J; Jiang P; Lin WL; Dickson DW; Wszolek ZK
Neurology; 2024 Jun; 102(11):e209437. PubMed ID: 38759141
[TBL] [Abstract][Full Text] [Related]
12. Identification of Selective Imidazopyridine CSF1R Inhibitors.
Kane JL; Asmussen G; Batchelor J; Cromwell M; Fezoui M; Fitzgerald M; Giese B; Gladysheva T; Holley S; Keefe K; Kothe M; Lam B; Lim S; Liu J; Ma L; Metz M; Scholte AA; Shum P; Wei L; Woodworth L; Edling A
ACS Med Chem Lett; 2024 May; 15(5):722-730. PubMed ID: 38746878
[TBL] [Abstract][Full Text] [Related]
13. Acute leukemia with predominantly myeloid differentiation and TBL1XR1::CSF1R fusion.
Kumar J; Petrova-Drus K
Blood; 2023 Oct; 142(14):1253. PubMed ID: 37796515
[No Abstract] [Full Text] [Related]
14. Synergistic Inhibition Guided Fragment-Linking Strategy and Quantitative Structure-Property Relationship Modeling To Design Inhalable Therapeutics for Asthma Targeting CSF1R.
Vaid TM; Demissie R; Kwon Y; Tran T; Moon HG; Villegas JA; Park GY; Johnson ME; Lee H
ACS Omega; 2023 Jun; 8(23):20505-20512. PubMed ID: 37323402
[TBL] [Abstract][Full Text] [Related]
15. Identification of functionally primitive and immunophenotypically distinct subpopulations in secondary acute myeloid leukemia by mass cytometry.
Bandyopadhyay S; Fowles JS; Yu L; Fisher DAC; Oh ST
Cytometry B Clin Cytom; 2019 Jan; 96(1):46-56. PubMed ID: 30426661
[TBL] [Abstract][Full Text] [Related]
16. First-in-class DAPK1/CSF1R dual inhibitors: Discovery of 3,5-dimethoxy-N-(4-(4-methoxyphenoxy)-2-((6-morpholinopyridin-3-yl)amino)pyrimidin-5-yl)benzamide as a potential anti-tauopathies agent.
Farag AK; Hassan AHE; Jeong H; Kwon Y; Choi JG; Oh MS; Park KD; Kim YK; Roh EJ
Eur J Med Chem; 2019 Jan; 162():161-175. PubMed ID: 30445265
[TBL] [Abstract][Full Text] [Related]
17.
Konno T; Kasanuki K; Ikeuchi T; Dickson DW; Wszolek ZK
Neurology; 2018 Dec; 91(24):1092-1104. PubMed ID: 30429277
[TBL] [Abstract][Full Text] [Related]
18. Whole-genome and transcriptome profiling of a metastatic thyroid-like follicular renal cell carcinoma.
Ko JJ; Grewal JK; Ng T; Lavoie JM; Thibodeau ML; Shen Y; Mungall AJ; Taylor G; Schrader KA; Jones SJM; Kollmannsberger C; Laskin J; Marra MA
Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30446580
[TBL] [Abstract][Full Text] [Related]
19. When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter.
Roloff GW; Griffiths EA
Blood Adv; 2018 Nov; 2(21):3070-3080. PubMed ID: 30425072
[TBL] [Abstract][Full Text] [Related]
20. High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action.
Adams HC; Stevenaert F; Krejcik J; Van der Borght K; Smets T; Bald J; Abraham Y; Ceulemans H; Chiu C; Vanhoof G; Usmani SZ; Plesner T; Lonial S; Nijhof I; Lokhorst HM; Mutis T; van de Donk NWCJ; Sasser AK; Casneuf T
Cytometry A; 2019 Mar; 95(3):279-289. PubMed ID: 30536810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
